title: Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
authors: Multiple Sclerosis Centre, Federico II University, Italy robertalanzillo@libero.it roberta.lanzillo@unina.it.
authors: Roberta
authors: R
authors: Lanzillo
authors: Multiple Sclerosis Centre, Federico II University, Italy.
authors: Marcello
authors: M
authors: Moccia
authors: Multiple Sclerosis Centre, Federico II University, Italy.
authors: Antonio
authors: A
authors: Carotenuto
authors: Multiple Sclerosis Centre, Federico II University, Italy.
authors: Veria
authors: V
authors: Vacchiano
authors: Multiple Sclerosis Centre, Federico II University, Italy.
authors: Barbara
authors: B
authors: Satelliti
authors: L'altrastatistica srl, Rome, Italy.
authors: Valentina
authors: V
authors: Panetta
authors: Multiple Sclerosis Centre, Federico II University, Italy.
authors: Vincenzo
authors: V
authors: Brescia Morra
mesh_terms: D018592:Cross-Over Studies; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D007279:Injections, Subcutaneous / Q000009:adverse effects; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D010147:Pain Measurement; D063465:Skin Cream / Q000627:therapeutic use; D014812:Vitamin K / Q000008:administration & dosage*
chemical_list: D007155:Immunologic Factors; D014812:Vitamin K; D016899:Interferon-beta